Author

Neetu Razdan

Observed name: N. Razdan

Institution: AstraZeneca (United States)

Observed institutions: AstraZeneca (Sweden), AstraZeneca (United States), Rutgers Health, Rutgers Cancer Institute, Rutgers New Jersey Medical School

OpenAlex ID: A5014956668

Telomere dysfunction promotes transdifferentiation of human fibroblasts into myofibroblasts

2018 · Neetu Razdan, Themistoklis Vasilopoulos, et al. · Aging Cell · 74

Genetic architecture of telomere length in 462,666 UK Biobank whole-genome sequences

2024 · Oliver S. Burren, Ryan S. Dhindsa, et al. · Nature Genetics · 59

Stn1 is critical for telomere maintenance and long‐term viability of somatic human cells

2015 · Virginia Boccardi, Neetu Razdan, et al. · Aging Cell · 28

Genetic architecture of telomere length in 462,675 UK Biobank whole-genome sequences

2023 · Oliver S. Burren, Ryan S. Dhindsa, et al. · medRxiv · 7

Clearance of Senescent Cells by BCL XL ‐ PROTAC : A Novel Approach to Treat COPD ?

2026 · Justine V. Devulder, Peter S. Fenwick, et al. · Aging Cell · 1

Effect of the novel senolytic drug, BCL-xL PROTAC, on small airway epithelial cells in COPD

2024 · Justine Devulder, Peter Fenwick, et al. · 1

Prevention of Replicative Senescence in IPF by Telomerase Enhancement

2022 · J.R. Connor, N. Razdan, et al. · 1

Effect of the novel senolytic drug, BCL-xL-PROTAC, on small airway fibroblasts in COPD

2025 · Justine Devulder, Peter Fenwick, et al.

Works count: 8

Citation count: 170

H-index: 4

I10-index: 3